The pathology group is multidisciplinary and integrates pathologists, hematologists, cytogeneticians and molecular biologists.
The main goals of the group are:
To diagnose and define the morphological, phenotypic, genetic and molecular characteristics of all the tumor samples included in the genome project.
To verify and validate in large series of patients the genomic alterations found in the sequencing studies.
To determine the pathological implications of the genomic alterations detected in the genomic studies.
To characterize the functional implications of the genomic aberrations identified in the genomic studies.